Editor’s note: This story was updated at 4:20 p.m. March 29, 2022 — The FDA today authorized Americans over the age of 50 to receive a second COVID-19 booster shot, even though many top infectious disease experts questioned the need before the agency’s decision. The FDA granted emergency use authorization for both Pfizer and Moderna … Read more
Dec. 23, 2021 — The FDA has granted emergency use authorization to Merck’s antiviral drug to treat adults with mild to moderate COVID-19 who are at risk for severe disease. Similar to FDA authorization of another antiviral pill regimen — ritonavir plus nirmatrelvir, or Paxlovid — granted to Pfizer on Wednesday, molnupiravir (brand name Lagevrio) … Read more
By Phil Galewitz, Kaiser Health News Friday, September 25, 2020 (Kaiser News) — President Donald Trump, outlining his “America First Health Plan” Thursday, announced that his administration will allow the importation of prescription drugs from Canada. The final plan clears the way for Florida and other states to implement a program bringing medications … Read more
Aug. 11, 2020 — Before completing clinical trials to ensure the vaccine is safe and effective, the Russian government has gone ahead and approved a vaccine against the new coronavirus, the New York Times reported Tuesday. According to Russian President Vladimir Putin, the vaccine works “effectively enough.” The premature approval of a vaccine … Read more